Phase II study of low-dose decitabine in combination with imatinib mesylate in patients with accelerated or myeloid blastic phase of chronic myelogenous leukemia. (Q40459776)
Jump to navigation
Jump to search
scientific article published on March 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of low-dose decitabine in combination with imatinib mesylate in patients with accelerated or myeloid blastic phase of chronic myelogenous leukemia. |
scientific article published on March 2007 |
Statements
1 reference
Phase II study of low-dose decitabine in combination with imatinib mesylate in patients with accelerated or myeloid blastic phase of chronic myelogenous leukemia. (English)
1 reference
Hagop M Kantarjian
1 reference
Srdan Verstovsek
1 reference
Jorge Cortes
1 reference
Guillermo Garcia-Manero
1 reference
Susan O'brien
1 reference
Jean-Pierre J Issa
1 reference
Yasuhiro Oki
1 reference
Vazganush Gharibyan
1 reference
Gail M Morris
1 reference
Dan Jones
1 reference
1 March 2007
1 reference
1 reference
Identifiers
1 reference